Publications by authors named "Stacey Stein"

Claim this Profile
B
Biliary Tract Cancers, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology.
Al B Benson, Michael I D'Angelica, Thomas Abrams, Aijaz Ahmed, Mehmet Akce, Stacey Stein

J Natl Compr Canc Netw· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are all programmed cell death protein 1 inhibitors the same?
Jochen H Lorch, Stacey Stein, Martin J Edelman

Front Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor response assessment in hepatocellular carcinoma treated with immunotherapy: imaging biomarkers for clinical decision-making.
Rabea Sobirey, Nickolai Matuschewski, Moritz Gross, MingDe Lin, Tabea Kao, Stacey Stein

Eur Radiol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology, treatment and outcomes of gastroenteropancreatic neuroendocrine neoplasms.
Johannes Uhlig, James Nie, Joanna Gibson, Michael Cecchini, Stacey Stein

Sci Rep· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perioperative Modified FOLFIRINOX for Resectable Pancreatic Cancer: A Nonrandomized Controlled Trial.
Michael Cecchini, Ronald R Salem, Marie Robert, Suzanne Czerniak, Ondrej Blaha, Stacey Stein

JAMA Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A single arm phase 2 clinical trial of YIV-906 with neoadjuvant concurrent chemo-radiation therapy in patients with locally advanced rectal cancer.
Nipun Verma, Kimberly L Johung, Jeremy Kortmansky, Wajih Zaheer, Jill Lacy, Stacey Stein

J Gastrointest Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NCI10066: a Phase 1/2 study of olaparib in combination with ramucirumab in previously treated metastatic gastric and gastroesophageal junction adenocarcinoma.
Michael Cecchini, James M Cleary, Yu Shyr, Joseph Chao, Nataliya Uboha, Stacey Stein

Br J Cancer· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NCCN Guidelines® Insights: Biliary Tract Cancers, Version 2.2023.
Al B Benson, Michael I D'Angelica, Thomas Abrams, Daniel E Abbott, Aijaz Ahmed, Stacey Stein

J Natl Compr Canc Netw· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative DNA Repair Biomarkers and Immune Profiling for Temozolomide and Olaparib in Metastatic Colorectal Cancer.
Michael Cecchini, Janie Y Zhang, Wei Wei, Jeffrey Sklar, Jill Lacy, Stacey M Stein

Cancer Res Commun· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-operative chemoradiotherapy with or without induction chemotherapy for operable locally-advanced esophageal cancer.
Gabrielle W Peters, Wesley Talcott, Nicholas V Peters, Andrew Dhanasopan, Jill Lacy, Stacey Stein

J Gastrointest Oncol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical care in hepatocellular carcinoma: A mixed methods assessment of experiences and challenges of oncology professionals.
Ginny Jacobs, Deborah A Boyle, Hashem B El-Serag, Robert J Lewandowski, Stacey M Stein

Cancer Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiagent Chemotherapy Followed by Stereotactic Body Radiotherapy Versus Conventional Radiotherapy for Resected Pancreas Cancer.
Meriem Mokhtech, Joseph A Miccio, Kimberly Johung, Michael Cecchini, Stacey Stein

Am J Clin Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-1 targeted immunotherapy for advanced hepatocellular carcinoma: current utilization and outcomes in the USA.
Johannes Uhlig, Stacey Stein, Hyun S Kim

Future Oncol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
Yale Precision Medicine Tumor Board: reawakening the guardian of the genome.
Michael J Grant, Karin E Finberg, Zenta Walther, Stacey M Stein, Jill Lacy

Lancet Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes of first line FOLFIRINOX gemcitabine plus nab-paclitaxel in metastatic pancreatic cancer at the Yale Smilow Hospital System.
Timil Patel, Joseph Miccio, Michael Cecchini, Thejal Srikumar, Stacey Stein

J Gastrointest Oncol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world association of HER2/ concordance with trastuzumab clinical benefit in advanced esophagogastric cancer.
Stacey M Stein, Jeremy Snider, Siraj M Ali, Rebecca A Miksad, Brian M Alexander

Future Oncol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, Efficacy, and Biomarker Results from a Phase Ib Study of the Anti-DKK1 Antibody DKN-01 in Combination with Pembrolizumab in Advanced Esophagogastric Cancers.
Samuel J Klempner, Johanna C Bendell, Victoria Meucci Villaflor, Laura LaNiel Tenner, Stacey M Stein

Mol Cancer Ther· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Moving Beyond the Momentum: Innovative Approaches to Clinical Trial Implementation.
Cathy Eng, Emerson Y Chen, Jane Rogers, Mark Lewis, Jonathan Strosberg, Paul Oberstein, Stacey Stein

JCO Oncol Pract· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of chronic viral hepatitis on prognostic value of inflammatory biomarkers in hepatocellular carcinoma.
Cortlandt M Sellers, Johannes Uhlig, Johannes M Ludwig, Jeffrey S Pollak, Tamar H Taddei, Stacey M Stein

Cancer Med· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reliable prediction of survival in advanced-stage hepatocellular carcinoma treated with sorafenib: comparing 1D and 3D quantitative tumor response criteria on MRI.
Luzie A Doemel, Julius Chapiro, Fabian Laage Gaupp, Lynn Jeanette Savic, Ahmet S Kucukkaya, Stacey M Stein

Eur Radiol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1b expansion study of TAS-102 with oxaliplatin for refractory metastatic colorectal cancer.
Michael Cecchini, Jeremy S Kortmansky, Can Cui, Wei Wei, Jaykumar Ranchobdhai Thumar, Stacey Stein

Cancer· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
Al B Benson, Michael I D'Angelica, Daniel E Abbott, Daniel A Anaya, Robert Anders, Stacey Stein

J Natl Compr Canc Netw· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Margin negative resection and pathologic downstaging with multiagent chemotherapy with or without radiotherapy in patients with localized pancreas cancer: A national cancer database analysis.
Joseph A Miccio, Wesley J Talcott, Timil Patel, Henry S Park, Michael Cecchini, Stacey Stein

Clin Transl Radiat Oncol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microsatellite Instability and KRAS Mutation in Stage IV Colorectal Cancer: Prevalence, Geographic Discrepancies, and Outcomes From the National Cancer Database.
Johannes Uhlig, Michael Cecchini, Amar Sheth, Stacey Stein, Jill Lacy

J Natl Compr Canc Netw· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the Cost-effectiveness of Doublet Therapy in Metastatic BRAF Variant Colorectal Cancer.
Kishan K Patel, Stacey Stein, Jill Lacy, Mark O'Hara, Scott F Huntington

JAMA Netw Open· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis